Interim analysis of STEVIE, a single-arm, open-label, multicentre study to evaluate the safety of the hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Lear JT, Gore M, Guerrero-Urbano T, Herd R, Plummer R, Basset-Seguin N, Hansson J, Mitchell L, Starnawski M, Hauschild A, Fife K

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: British Association of Dermatologists 93rd Annual Meeting

Year of Conference: 2013

Pages: 2

Print publication date: 01/07/2013

Online publication date: 08/07/2013

ISSN: 0007-0963

Publisher: Wiley-Blackwell

URL: http://dx.doi.org/10.1111/bjd.12366

DOI: 10.1111/bjd.12366

Series Title: British Journal of Dermatology

ePrints